|Company name||Heron Therapeutics, Inc.|
NEW YORK, July 30, 2019 – Bragar Eagel & Squire is investigating certain officers and directors of Healthcare Services Group, Inc. (NASDAQ: HRTX) following a class action complaint that was filed against Healthcare Services on March 22, 2019.
The complaint alleges that throughout the class period, defendants made materially false and misleading statements regarding the company’s business, operational and compliance policies. Specifically, the complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: defendants engaged in a scheme to deceive the market and a course of conduct that artificially inflated the price of Healthcare Services securities and misrepresented the value of the company’s business and prospects by overstating its earnings and concealing the significant defects in its internal controls.
If you are a long-term stockholder of Heron Therapeutics securities, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at email@example.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.